Administering naloxone: is the answer under our noses?

Show simplified metadata
dc.contributor.authorBisset, Elspeth
dc.date.accessioned2020-11-23T15:34:22Z
dc.date.available2020-11-23T15:34:22Z
dc.date.issued2009-06-01
dc.description.abstractThe intranasal (IN) administration of naloxone to treat opioid overdoses offers many benefi ts over the current, often problematic intravenous and intramuscular routes. Such problems include using sharps around potentially aggressive patients; a high risk of transmitting blood-borne infections and diffi culty obtaining intravenous access in injecting drug users. A literature search was undertaken to examine the effectiveness of the IN route of naloxone administration in comparison to these other routes. Research suggests that the IN route is safe to introduce into practice and it is effective: the time taken from ambulance staff arriving at opioid overdose patients to them responding to IN naloxone appears to equal that of the intravenous route. Intranasal naloxone is not yet licensed for use in the UK and this needs to be reviewed. In the future this method of drug administration should result in considerable benefits and improved safety to both ambulance staff and patients, particularly for the treatment of opioid overdoses. Abstract published with permission
dc.identifier.citationBissett, E., 2009. Administering naloxone: is the answer under our noses? Journal of Paramedic Practice, 1 (9), 359-367.en_US
dc.identifier.doi10.12968/jpar.2009.1.9.42994
dc.identifier.issn1759-1376
dc.identifier.issn2041-9457
dc.identifier.urihttp://hdl.handle.net/20.500.12417/933
dc.language.isoenen_US
dc.source.journaltitleJournal of Paramedic Practiceen_US
dc.subjectEmergency Medical Servicesen_US
dc.subjectNaloxoneen_US
dc.subjectDrug Overdoseen_US
dc.subjectIntranasal Drug Administrationen_US
dc.subjectOpioidsen_US
dc.titleAdministering naloxone: is the answer under our noses?en_US
dc.typeJournal Article/Review
dcterms.dateAccepted2020-09-21
dspace.entity.typePublication
html.description.abstractThe intranasal (IN) administration of naloxone to treat opioid overdoses offers many benefi ts over the current, often problematic intravenous and intramuscular routes. Such problems include using sharps around potentially aggressive patients; a high risk of transmitting blood-borne infections and diffi culty obtaining intravenous access in injecting drug users. A literature search was undertaken to examine the effectiveness of the IN route of naloxone administration in comparison to these other routes. Research suggests that the IN route is safe to introduce into practice and it is effective: the time taken from ambulance staff arriving at opioid overdose patients to them responding to IN naloxone appears to equal that of the intravenous route. Intranasal naloxone is not yet licensed for use in the UK and this needs to be reviewed. In the future this method of drug administration should result in considerable benefits and improved safety to both ambulance staff and patients, particularly for the treatment of opioid overdoses. Abstract published with permissionen_US
refterms.dateFirstOnline2013-09-29
refterms.panelUnspecifieden_US
relation.isAuthorOfPublicatione495c463-e5c3-4b5b-9d69-08ffef58728a
relation.isAuthorOfPublication.latestForDiscoverye495c463-e5c3-4b5b-9d69-08ffef58728a
rioxxterms.licenseref.startdate2020-09-21
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden_US
rioxxterms.versionNAen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Publications - North West Ambulance Service